OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RNA-based therapy in the management of lipid disorders: a review
Dirk Blom, A. David Marais, Rajen Moodley, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Dirk Blom, A. David Marais, Rajen Moodley, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Showing 17 citing articles:
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
Christie M. Ballantyne, Szilárd Vasas, Masoud Azizad, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 10, pp. 899-912
Closed Access | Times Cited: 66
Christie M. Ballantyne, Szilárd Vasas, Masoud Azizad, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 10, pp. 899-912
Closed Access | Times Cited: 66
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
Bożena Sosnowska, Stanisław Surma, Maciej Banach
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1573-1573
Open Access | Times Cited: 41
Bożena Sosnowska, Stanisław Surma, Maciej Banach
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1573-1573
Open Access | Times Cited: 41
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 39-67
Open Access | Times Cited: 12
Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 39-67
Open Access | Times Cited: 12
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 10
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 10
Lipids dysregulation in diseases: core concepts, targets and treatment strategies
Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
Jung Ho Han, Eun‐Ji Lee, Mi-Ju Park, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Jung Ho Han, Eun‐Ji Lee, Mi-Ju Park, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment
John R. Burnett, Amanda J. Hooper
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 873-878
Closed Access | Times Cited: 14
John R. Burnett, Amanda J. Hooper
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 873-878
Closed Access | Times Cited: 14
The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study
Wongsakorn Luangphiphat, Pinidphon Prombutara, Praewpannarai Jamjuree, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317202-e0317202
Open Access
Wongsakorn Luangphiphat, Pinidphon Prombutara, Praewpannarai Jamjuree, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317202-e0317202
Open Access
RNA therapeutics in cardiovascular medicine
Tulsi Ram Damase, John P. Cooke
Current Opinion in Cardiology (2025)
Closed Access
Tulsi Ram Damase, John P. Cooke
Current Opinion in Cardiology (2025)
Closed Access
RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management
Abbas Mohammadi, Azin Karimian, Kasra Shokri, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access
Abbas Mohammadi, Azin Karimian, Kasra Shokri, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access
RNA in cardiovascular disease: A new frontier of personalized medicine
Toufik Abdul-Rahman, Ileana Lizano-Jubert, Zarah Sophia Blake Bliss, et al.
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 3
Toufik Abdul-Rahman, Ileana Lizano-Jubert, Zarah Sophia Blake Bliss, et al.
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 3
Gene silencing by RNA interference: a review
Suresh Malakondaiah, Angeline Julius, Divyadharshini Ponnambalam, et al.
Genome Instability & Disease (2024) Vol. 5, Iss. 5, pp. 225-241
Closed Access | Times Cited: 3
Suresh Malakondaiah, Angeline Julius, Divyadharshini Ponnambalam, et al.
Genome Instability & Disease (2024) Vol. 5, Iss. 5, pp. 225-241
Closed Access | Times Cited: 3
RNA Combined with Nanoformulation to Advance Therapeutic Technologies
Eduarda Lima, Déborah dos Santos, Atena Liriel Souza, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 7
Eduarda Lima, Déborah dos Santos, Atena Liriel Souza, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 7
Petits ARN interférents : applications potentielles pour les néphrologues Small interfering RNA: potential applications for nephrologists
Sandrine Lemoine, Marie Courbebaisse
Néphrologie & Thérapeutique (2022) Vol. 18, Iss. 6, pp. 6S1-6S6
Closed Access | Times Cited: 1
Sandrine Lemoine, Marie Courbebaisse
Néphrologie & Thérapeutique (2022) Vol. 18, Iss. 6, pp. 6S1-6S6
Closed Access | Times Cited: 1
Noncoding RNAs in atherosclerosis
A. Yaël Nossent, Christoph J. Binder
Atherosclerosis (2023) Vol. 374, pp. 21-23
Open Access
A. Yaël Nossent, Christoph J. Binder
Atherosclerosis (2023) Vol. 374, pp. 21-23
Open Access
LDL's unexpected travel partners in the road to atherosclerosis
Soumaya Ben‐Aicha, Borja Ibáñez
Cardiovascular Research (2023) Vol. 119, Iss. 13, pp. e146-e148
Open Access
Soumaya Ben‐Aicha, Borja Ibáñez
Cardiovascular Research (2023) Vol. 119, Iss. 13, pp. e146-e148
Open Access
Lipoproteína (a) y oligonucleótidos antisentido
Jeiver Aldúbar Contreras Romero, Kevin Guillermo Castro Gomez, Maria Paula Morales Ortigoza, et al.
Revista Colombiana de Endocrinología Diabetes & Metabolismo (2023) Vol. 10, Iss. 3
Open Access
Jeiver Aldúbar Contreras Romero, Kevin Guillermo Castro Gomez, Maria Paula Morales Ortigoza, et al.
Revista Colombiana de Endocrinología Diabetes & Metabolismo (2023) Vol. 10, Iss. 3
Open Access
